Staying sharp in Washington, D.C.

September 26, 2007

WHAT:
Brain health of aging African Americans and Hispanics will be the focus of a Staying Sharp session on October 6 at the Lincoln Theatre in Washington, DC. Part of a highly recognized series, the program will explore ongoing research into the treatment of depression and stroke prevention in minority populations. Panelists will also discuss memory loss and present tips for successful aging.

WHEN:
Saturday, October 6, 2007
10:00AM - 12:00PM
(Free and open to the public)

WHERE:
Lincoln Theatre
1215 U Street, NW
Washington, D.C.

WHO:
The program is sponsored by The Dana Alliance for Brain Initiatives, in partnership with NRTA: AARP's Educator Community and the MetLife Foundation. Featured speakers will be:
-end-
The Dana Alliance for Brain Initiatives is a nonprofit organization of 260 leading neuroscientists, including ten Nobel laureates, committed to advancing public awareness about the progress and benefits of brain research. NRTA: AARP's Educator Community is America's foremost network of 50+ adults and organizations with a passion and affinity for education and learning.

Staying Sharp is a series of public forums and educational booklets for older Americans. Since its inception in 1994, the series has been attended by more than 25,000 people in 26 cities across the United States. For more information, please visit: http://www.dana.org/danaalliances/programs/stayingsharp/

DANA Foundation

Related Stroke Prevention Articles from Brightsurf:

New drug targets clots: A potential treatment for heart attack and stroke prevention
Monash researchers have developed a drug that can be potentially given as a preventative against heart attack.

Heart attack prevention lags for people with stroke, peripheral artery disease
Although all three conditions can lead to heart attack, people with stroke or peripheral artery disease were less likely to receive preventive treatments to prevent heart attack than people with coronary artery disease.

Type 2 diabetes linked to worse cognitive performance after a stroke; prediabetes not linked, but prevention needed
An analysis of seven international studies found people with Type 2 diabetes, but not those with prediabetes, had worse cognitive function three to six months after a stroke.

Hispanic individuals benefit from skills-based stroke prevention intervention
A culturally tailored program used when discharging stroke patients from the hospital helped to lower blood pressure among Hispanic individuals one year later, finds a new study led by researchers at NYU College of Global Public Health.

Study provides 10-year risk estimates for dementia, which may help with prevention in high-risk individuals who potentially could benefit from early targeted prevention
A Danish study provides 10-year absolute risk estimates for dementia specific to age, sex and common variation in the APOE gene, which may help identify high-risk individuals who potentially could benefit from early targeted prevention.

Keeping cost from getting in the way of stroke prevention
Stroke survivors under age 65 are having less trouble paying for the crucial medications that can stave off a bigger health catastrophe, thanks to expanded Medicaid and other Affordable Care Act provisions.

Stroke prevention drug combo shows promise, study says
If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research published in The New England Journal of Medicine.

Education and feedback improve use of stroke prevention drugs in AF (IMPACT-AF)
Education of healthcare providers and patients with atrial fibrillation has led to a 9 percent absolute increase in the use of anticoagulation therapies to reduce stroke, according to late-breaking results from the IMPACT-AF trial presented today in a Hot Line LBCT Session at ESC Congress1 and published in the Lancet.

Stroke prevention may also reduce dementia
Ontario's stroke prevention strategy appears to have had an unexpected, beneficial side effect: a reduction also in the incidence of dementia among older seniors.

Risk of hemorrhage with statins and stroke prevention drug combination
Two commonly used statins can increase the risk of hemorrhage when combined with dabigatran etexilate, a drug often used for preventing stroke in patients with atrial fibrillation, according to a study in CMAJ.

Read More: Stroke Prevention News and Stroke Prevention Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.